NASDAQ · Financial Statements

NERV (NERV) Financial Statements

$4.48 NASDAQ: NERV Market Cap $208.72M

NERV most recently reported annual revenue of $0, net profit of $-293.0M. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

Annual Financials (USD)

Metric20212022202320242025
Revenue$0$0$0$0$0
Operating Profit$-45.0M$-25.0M$-23.0M$-22.0M$-15.0M
Net Profit$-50.0M$-32.0M$-30.0M$1.0M$-293.0M
EPS$-9.35$-6.01$-4.61$0.19$-34.67
Op Margin

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$77.0M$55.0M$57.0M$37.0M$98.0M
Total Liabilities$69.0M$75.0M$85.0M$63.0M$239.0M
Cash$61.0M$36.0M$41.0M$21.0M$82.0M
Borrowings$0$0$0$0$65.0M

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$-25.0M$-25.0M$-15.0M$-20.0M$-13.5B
Investing Cash Flow$0$0$0$0$0
Financing Cash Flow$60.0M$0$0$0$74.4B
Net Cash Flow$35.0M$-25.0M$5.0M$-20.0M$60.9B
Free Cash Flow$-25.0M$-25.0M$-15.0M$-20.0M$-13.5B

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA-0.58
FCF Yield-7423.33%
Quick Ratio20.14
Interest Coverage0.00
Return 1Y109.50%
Return 3Y-58.86%
Return 5Y-71.44%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
NERV Overview NERV Dividend Run Stock Screener